Administrative Core
行政核心
基本信息
- 批准号:10684067
- 负责人:
- 金额:$ 43.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAdministratorAdvanced DevelopmentAnalytical ChemistryAuthorization documentationAwardCalendarChemicalsCholinesterase InhibitorsChronicCollaborationsCommunicationCommunitiesDataDatabase Management SystemsEducational workshopEnsureEnvironmental HealthEquipment and supply inventoriesEventFederal GovernmentFosteringFundingGeneral PopulationGoalsGovernment AgenciesGrantHazardous SubstancesHuman ResourcesIACUCIndividualIntellectual PropertyIntoxicationInvestigational DrugsLeadershipLegal patentLogisticsManuscriptsMedical ResearchMissionMonitorNeurologicOnline SystemsOrganophosphatesOutcomePharmaceutical ChemistryPilot ProjectsPoliciesProceduresPubMedPublicationsQualifyingReadinessReagentRegulationReportingResearchResearch InstituteResearch PersonnelResearch Project GrantsResource SharingSafetyScienceScientistSecureSecurityStrategic PlanningSystemTechnology TransferTherapeuticTherapeutic AgentsTrainingUnited States Food and Drug AdministrationUnited States National Institutes of HealthUniversitiesWorkauthoritycentral databasechemical threatcholinergicdata sharingeducation researchinnovationinterestmedical countermeasuremeetingsmemberoperationpre-Investigational New Drug meetingprogramsrecruitresearch and developmentsuccesssynergismtherapeutic candidatetherapeutic developmenttimelineweb site
项目摘要
Project Summary – Administrative Core
The overall objective of the new UC Davis CounterACT Center of Excellence is to identify and advance the
development of therapeutic strategies for mitigating long-term, adverse neurologic consequences in individuals
who survive the cholinergic crisis triggered by acute intoxication with organophosphate (OP) cholinesterase
inhibitors. The Center is comprised of three scientific Projects, three scientific Cores, a Research Education
Core, an Emerging Science and Scientists Pilot Project Program, and multiple committees — all of which will
work closely together to ensure success. The Administrative Core will centralize coordination, communication
and integration among the Projects and Cores and foster synergy across the Center, ultimately ensuring the
Center meets annual milestones established in collaboration with NIH CounterACT program officer(s). Activities
will include providing overall scientific leadership, fiscal oversight, and logistical support as well as assistance
with disseminating research findings and encouraging and facilitating data sharing with external investigators.
Additionally, the Administrative Core will coordinate Center interactions with the UC Davis administration and
external entities, such as the NIH CounterACT administration, the Center’s External Advisory Board, the larger
CounterACT research community, the U.S. Food and Drug Administration (FDA), the Biomedical Advanced
Research and Development Authority (BARDA), and potential commercial partners. The Core’s objectives are
to: (1) Provide scientific leadership and logistics support to coordinate and integrate Center activities and
promote interactions among Center investigators to meet annual Center milestones; (2) Administer the Emerging
Science and Scientists Pilot Project Program (ESSP3); (3) Facilitate data and resource sharing among Center
investigators and other CounterACT investigators; (4) Provide budgetary oversight and grant management; (5)
Ensure the safety and security of personnel, materials, data and facilities; (6) Pursue intellectual property (IP)
strategies, and identify, engage and coordinate communications with commercial partners; and (7) Coordinate
with FDA, BARDA and other federal government agencies.
项目摘要-行政核心
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pamela J Lein其他文献
Pamela J Lein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pamela J Lein', 18)}}的其他基金
Project 1: Reduction of Pro-Inflammatory Signaling
项目 1:减少促炎症信号传导
- 批准号:
10684082 - 财政年份:2022
- 资助金额:
$ 43.21万 - 项目类别:
Ketogenic diet approaches to slow disease progression in a rat model of Alzheimer's disease
生酮饮食方法可减缓阿尔茨海默病大鼠模型的疾病进展
- 批准号:
9977496 - 财政年份:2020
- 资助金额:
$ 43.21万 - 项目类别:
Identifying Molecular Targets for the Proconvulsant Activity of TETS
确定 TETS 促惊厥活性的分子靶点
- 批准号:
9905564 - 财政年份:2019
- 资助金额:
$ 43.21万 - 项目类别:
Does air pollution increase risk of AD in a genetically susceptible animal model?
空气污染是否会增加遗传易感动物模型患 AD 的风险?
- 批准号:
9126737 - 财政年份:2016
- 资助金额:
$ 43.21万 - 项目类别:
Mitigation of Neurological Damage Following Seizures
减轻癫痫发作后的神经损伤
- 批准号:
10204125 - 财政年份:2012
- 资助金额:
$ 43.21万 - 项目类别:
Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication
针对 TETS 和 OP 中毒的新型抗惊厥药和神经保护疗法
- 批准号:
9142832 - 财政年份:2012
- 资助金额:
$ 43.21万 - 项目类别:
Novel Anticonvulsant and Neuroprotective Therapies for TETS and OP Intoxication
针对 TETS 和 OP 中毒的新型抗惊厥和神经保护疗法
- 批准号:
10204117 - 财政年份:2012
- 资助金额:
$ 43.21万 - 项目类别:
Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication
针对 TETS 和 OP 中毒的新型抗惊厥药和神经保护疗法
- 批准号:
8925299 - 财政年份:2012
- 资助金额:
$ 43.21万 - 项目类别:
相似海外基金
EAGER: Toward a Decentralized Cross-administrator Zone Management System: Policy and Technology
EAGER:走向去中心化的跨管理员区域管理系统:政策和技术
- 批准号:
2331936 - 财政年份:2023
- 资助金额:
$ 43.21万 - 项目类别:
Standard Grant
COLLABORATIVE RESEARCH: Social Influence in Eyewitness Identification Procedures: Do Blind Administrator Behaviors Magnify the Effects of Suspect Bias?
合作研究:目击者识别程序中的社会影响:盲目的管理员行为是否会放大嫌疑人偏见的影响?
- 批准号:
2043230 - 财政年份:2021
- 资助金额:
$ 43.21万 - 项目类别:
Continuing Grant
COLLABORATIVE RESEARCH: Social Influence in Eyewitness Identification Procedures: Do Blind Administrator Behaviors Magnify the Effects of Suspect Bias?
合作研究:目击者识别程序中的社会影响:盲目的管理员行为是否会放大嫌疑人偏见的影响?
- 批准号:
2043334 - 财政年份:2021
- 资助金额:
$ 43.21万 - 项目类别:
Continuing Grant
Making of the base for patient safety management skill of visiting nurse administrator by the web conference system
利用网络会议系统构建出诊护士管理者患者安全管理技能基础
- 批准号:
19K10768 - 财政年份:2019
- 资助金额:
$ 43.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of the nursing administrator training program to improve leadership behavior focused on emotional intelligence
制定护理管理人员培训计划,以改善以情商为重点的领导行为
- 批准号:
18K17464 - 财政年份:2018
- 资助金额:
$ 43.21万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Automated Network Management that Dynamically Reflects Administrator Intent
动态反映管理员意图的自动化网络管理
- 批准号:
18K18038 - 财政年份:2018
- 资助金额:
$ 43.21万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Administrator support perceived as useful for professional growth by novice psychiatric home-visit nursing staff
新手精神科家访护理人员认为管理员支持对专业成长有用
- 批准号:
17H07005 - 财政年份:2017
- 资助金额:
$ 43.21万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
The Facts and Problems on Management of Public Museums: Validation of Designated Administrator System
公共博物馆管理的事实与问题:指定管理员制度的验证
- 批准号:
17K01212 - 财政年份:2017
- 资助金额:
$ 43.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Study on Transformation of the School Administrator Preparation and Evaluation System in the United States
美国学校管理人员培养与评价体系转型研究
- 批准号:
26780449 - 财政年份:2014
- 资助金额:
$ 43.21万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The Family Court's Supervision of Property Administrator
家庭法院对财产管理人的监督
- 批准号:
26380108 - 财政年份:2014
- 资助金额:
$ 43.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)